SLNO - Soleno Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$53.00
DETAILS
HIGH:
$53.00
LOW:
$53.00
MEDIAN:
$53.00
CONSENSUS:
$53.00
DOWNSIDE:
0.02%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 0 | $0 | -- | -30,247 | SOLD |
| Greenblatt | 0 | $0 | -- | -13,702 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-18 | Hirano Patricia C | officer: SEE REMARKS | D-Return | 11,667 | $2.41 | $28K |
| 2026-05-18 | Norrett Kevin | officer: Chief Business Officer | D-Return | 4,000 | $43.65 | $175K |
| 2026-05-18 | Hirano Patricia C | officer: SEE REMARKS | D-Return | 22,702 | -- | -- |
| 2026-05-18 | Anish Bhatnagar | director, officer: CHIEF EXECUTIVE OFFICER | D-Return | 115,600 | $49.17 | $5.7M |
| 2026-05-18 | Manning Meredith | officer: Chief Commercial Officer | D-Return | 29,200 | $49.17 | $1.4M |
| 2026-05-18 | Hirano Patricia C | officer: SEE REMARKS | D-Return | 2,445 | $5.10 | $12K |
| 2026-05-18 | Joshi Manher | officer: Chief Development Officer | D-Return | 20,171 | -- | -- |
| 2026-05-18 | Hirano Patricia C | officer: SEE REMARKS | D-Return | 18,842 | $33.60 | $633K |
| 2026-05-18 | Huang Michael F. | officer: Sr. VP of Clinical Development | D-Return | 11,900 | $43.65 | $519K |
| 2026-05-18 | Manning Meredith | officer: Chief Commercial Officer | D-Return | 32,800 | $43.65 | $1.4M |
| 2026-05-18 | Yen Kristen | officer: SEE REMARKS | D-Return | 1,741 | $44.25 | $77K |
| 2026-05-18 | Yen Kristen | officer: SEE REMARKS | D-Return | 4,999 | $24.00 | $120K |
| 2026-05-18 | Yen Kristen | officer: SEE REMARKS | D-Return | 4,000 | $25.05 | $100K |
| 2026-05-18 | Yen Kristen | officer: SEE REMARKS | D-Return | 666 | $51.15 | $34K |
| 2026-05-18 | Volck Birgitte | director | D-Return | 2,666 | $5.03 | $13K |
| 2026-05-18 | Volck Birgitte | director | D-Return | 10,000 | $5.25 | $52K |
| 2026-05-18 | Sinclair Andrew | director | D-Return | 10,491 | -- | -- |
| 2026-05-18 | Pauls Matthew | director | D-Return | 10,491 | -- | -- |
| 2026-05-18 | Norrett Kevin | officer: Chief Business Officer | D-Return | 17,786 | -- | -- |
| 2026-05-18 | Manning Meredith | officer: Chief Commercial Officer | D-Return | 64,507 | -- | -- |
| 2026-05-18 | Manning Meredith | officer: Chief Commercial Officer | D-Return | 91,000 | $46.31 | $4.2M |
| 2026-05-18 | Huang Michael F. | officer: Sr. VP of Clinical Development | D-Return | 13,800 | $49.17 | $679K |
| 2026-05-18 | Fulk Jennifer | officer: CHIEF FINANCIAL OFFICER | D-Return | 39,200 | -- | -- |
| 2026-05-18 | Anish Bhatnagar | director, officer: CHIEF EXECUTIVE OFFICER | D-Return | 22,452 | $44.25 | $994K |
| 2026-05-18 | Anish Bhatnagar | director, officer: CHIEF EXECUTIVE OFFICER | D-Return | 52,709 | $2.41 | $127K |